Canales, Giancarlo De la Torre 
; Poluha, Rodrigo Lorenzi ; Lora, Victor Muñoz ; Ferreira, Dyna Mara Araújo Oliveira ; Stuginski-Barbosa, Juliana ; Bonjardim, Leonardo Rigoldi ; Cury, Altair Antoninha Del Bel ; Conti, Paulo César Rodrigues
Fonte: Clinical Oral Investigations. Unidade: FOB
Assuntos: TOXINAS, NERVO TRIGÊMEO, DOR FACIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANALES, Giancarlo De la Torre et al. Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects?. Clinical Oral Investigations, v. 23, n. 9, p. Se 2019, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00784-019-03026-4. Acesso em: 31 out. 2024.APA
Canales, G. D. la T., Poluha, R. L., Lora, V. M., Ferreira, D. M. A. O., Stuginski-Barbosa, J., Bonjardim, L. R., et al. (2019). Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects? Clinical Oral Investigations, 23( 9), Se 2019. doi:10.1007/s00784-019-03026-4NLM
Canales GD la T, Poluha RL, Lora VM, Ferreira DMAO, Stuginski-Barbosa J, Bonjardim LR, Cury AADB, Conti PCR. Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects? [Internet]. Clinical Oral Investigations. 2019 ; 23( 9): Se 2019.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00784-019-03026-4Vancouver
Canales GD la T, Poluha RL, Lora VM, Ferreira DMAO, Stuginski-Barbosa J, Bonjardim LR, Cury AADB, Conti PCR. Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects? [Internet]. Clinical Oral Investigations. 2019 ; 23( 9): Se 2019.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00784-019-03026-4
